LOUIS G LANGE
CIK 1238401 · EVP Cardiovascular Therapeutic · last filed 2026-03-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$852.1K
Companies
6
Total Filings
72
Lifetime Open-Market Net
-$20.78M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NAMSW | Director | 10,360 | $19.38 | $200.8K | -$2.09M | 10 | 2026-03-12 |
| BOLD | Director | 0 | $2.47 | $0 | -$9.35M | 19 | 2020-01-15 |
| CymaBay Therapeutics, Inc. (CBAY) Delisted | Director | — | $32.48 | — | $0 | 2 | 2015-06-30 |
| ESPR | Director | 204,803 | $3.18 | $651.3K | $199.0K | 1 | 2013-07-01 |
| GILD | EVP Cardiovascular Therapeutic | — | $134.32 | — | $0 | 2 | 2009-05-08 |
| CV THERAPEUTICS INC (CVTX) Delisted | Chairman & CEO | 490,432 | — | — | -$9.54M | 25 | 2009-04-17 |
Recent Filings · Page 2 of 8
72 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-02-21 | NAMSW | Buy (P) | +5,000 | $95.0K | EDGAR |
| 2024-01-03 | NAMSW | Grant (A) | — | $0 | EDGAR |
| 2020-01-15 | BOLD | Mixed | −315,375 | -$18.92M | EDGAR |
| 2019-12-27 | BOLD | Sell (S) | −11,000 | -$655.6K | EDGAR |
| 2019-09-25 | BOLD | Sell (S) | −11,000 | -$353.8K | EDGAR |
| 2019-06-26 | BOLD | Sell (S) | −21,000 | -$793.6K | EDGAR |
| 2019-03-27 | BOLD | Sell (S) | −21,558 | -$776.1K | EDGAR |
| 2019-02-08 | BOLD | Grant (A) | — | $0 | EDGAR |
| 2018-12-27 | BOLD | Sell (S) | −32,000 | -$595.8K | EDGAR |
| 2018-11-16 | BOLD | Sell (S) | −24,000 | -$539.8K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.